Dr.
Heba Waly, executive managing director of VACSERA, Dr. Saeed Aldayeh,
authorized agent of Exeed Industries, and Fareed Bilbeisi, CEO of Scope
Investment, signed the agreement. Dr. Khaled Abdel Ghaffar, Egypt's minister of
health and population, also attended the signing ceremony.
The
manufacturing facility will be built on a total area of about 6,400 square
meters, and it will have a production capability of 150 to 240 million units
per year. The VACSERA industrial facility in the Sixth of October City will
house this factory. The plan will be completed in the ensuing six months, and
manufacturing is anticipated to start in Q1 2024.
Bilbeisi
declared, "This agreement fits with Scope Investment's healthcare plan,
which involves growing and forming reliable alliances across the board in the
healthcare industry. I am optimistic about the beneficial effects that this
partnership will have due to the unmatched combined expertise that it brings
together. This endeavor represents yet another development in our growth in the
healthcare industry. With this initiative, Scope Investment hopes to offer the
people of Egypt and the Sub-Saharan region high-quality goods and services that
are affordable at rates that are competitive."
The
largest producer of serums, vaccines, and biological preparations in the Arab
Republic of Egypt, the Middle East, and Africa is the holding firm for
biological preparations and vaccines (VACSERA). Additionally, it has more than
100 years of expertise in this area. The
goal of this project is to create a joint stock business that specializes in
setting up, running, and maintaining auto-disable syringes and other medical
supplies. The goal is to meet the demands of the Egyptian market, as well as
those of the private sector and the needs of the country's fundamental
immunization program. Additionally, the Middle East and the continent of Africa
will become export markets for these crucial medical goods. Egyptian
businesses are reputed to have a competitive edge in terms of expertise, labor
costs, and an all-around welcoming investment climate
The
agreement also ensures the delivery of essential medical goods to Egypt,
Africa, and Asia's markets, enhancing the contributions and regional presence
of UAE-based businesses. Another significant step in the collaboration between
UAE and Egyptian businesses is the signing of this agreement.the signing of this new agreement, Scope Investment and National Holding
Company have made a major step toward increasing their investments in the area.
Leading
private investment firm Scope Investment is located in the United Arab
Emirates. The Abu Dhabi-based company is renowned for its specialized projects
that are founded on the idea of long-term, sustainable value creation. It
provides performance and effect to markets like the GCC, Asia, and Africa
through a variety of financial and investment strategies.
Scope
Investment has developed a sizable and diversified portfolio across healthcare,
real estate, retail, automotive, and ICT (information, communication, and
technology), spanning direct and passive investments, and public equities,
using deep sector knowledge and experience. To continue to develop competencies
in specialized areas, the group has a pipeline of projects in important growth
sectors.
Comments
Post a Comment